Piramal Enterprises has received an approval for the allotment of 1,250 Secured, Rated, Listed, Redeemable Principal Protected, Market Linked Non-Convertible Debentures (NCDs) each having a face value of Rs 10,00,000, aggregating to Rs 125 crore on private placement basis.
These Debentures are proposed to be listed on the Debt Segment and Capital Market Segment of National Stock Exchange of India (NSE) and BSE Limited respectively, and NSE being the designated Stock Exchange. The Meeting of Administrative Committee (‘Committee’) of the Board of Directors of the Company held on March 2, 2022 has approved allotment of the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
